Discordant activation of gene promoters for matrix metalloproteinases and tissue inhibitors of the metalloproteinases following myocardial infarction

Journal of Surgical Research

Volumn 172, Issue 1, 2012, Pages 59-67

  Mukherjee, Rupak ^a   Snipes, Jonathan M ^a   Saunders, Stuart M ^a   Zavadzkas, Juozas A ^a   Spinale, Francis G ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

matrix metalloproteinase; myocardial infarction; remodeling; tissue inhibitor of metalloproteinase

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENETIC TRANSCRIPTION; HEART INFARCTION; HEART LEFT VENTRICLE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ANIMALS; BETA-GALACTOSIDASE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; FEMALE; LIGATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; MYOCARDIUM; PROMOTER REGIONS, GENETIC; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VENTRICULAR REMODELING;

EID: 82955213551     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.06.015     Document Type: Article

References (36)

1. J.P. Cleutjens, J.C. Kandala, and E. Guarda Regulation of collagen degradation in the rat myocardium after infarction J Mol Cell Cardiol 27 1995 1281
2. J.P. Cleutjens, and E.E. Creemers Integration of concepts: Cardiac extracellular matrix remodeling after myocardial infarction J Card Fail 8 2002 S344
3. E.E. Creemers, J.N. Davis, and A.M. Parkhurst Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice Am J Physiol Heart Circ Physiol 284 2003 H364
4. E.E. Creemers, J.P. Cleutjens, and J.F. Smits Matrix metalloproteinase inhibition after myocardial infarction: A new approach to prevent heart failure? Circ Res 89 2001 201
5. F.G. Spinale, and N.M. Wilbur Matrix metalloproteinase therapy in heart failure Curr Treat Options Cardiovasc Med 11 2009 339
6. F.G. Spinale Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function Physiol Rev 87 2007 1285
7. J. Chen, C.H. Tung, and J.R. Allport Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction Circulation 111 2005 1800
8. R. Mukherjee, J.T. Mingoia, and J.A. Bruce Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction Am J Physiol Heart Circ Physiol 291 2006 H2216
9. J.T. Peterson, H. Li, and L. Dillon Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat Cardiovasc Res 46 2000 307
10. A.M. Romanic, C.L. Burns-Kurtis, and B. Gout Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit Life Sci 68 2001 799
11. Y. Sun, J.P. Cleutjens, and A.A. Diaz-Arias Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat Cardiovasc Res 28 1997 1423
12. Z.Y. Tao, M.A. Cavasin, and F. Yang Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice Life Sci 74 2004 1561
13. E.M. Wilson, S.L. Moainie, and J.M. Baskin Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling Circulation 107 2003 2857
14. A. Ducharme, S. Frantz, and M. Aikawa Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction J Clin Invest 106 2000 55
15. S. Hayashidani, H. Tsutsui, and M. Ikeuchi Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction Am J Physiol Heart Circ Physiol 285 2003 H1229
16. W.M. Yarbrough, R. Mukherjee, and T.A. Brinsa Matrix metalloproteinase inhibition modifies left ventricular remodeling after myocardial infarction in pigs J Thorac Cardiovasc Surg 125 2003 602
17. R. Mukherjee, T.A. Brinsa, and K.B. Dowdy Myocardial infarct expansion and matrix metalloproteinase inhibition Circulation 107 2003 618
18. L.E. Rohde, A. Ducharme, and L.H. Arroyo Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice Circulation 99 1999 3063
19. J.S. Ikonomidis, J.W. Hendrick, and A.M. Parkhurst Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: Effects of exogenous MMP inhibition Am J Physiol Heart Circ Physiol 288 2005 H149
20. M.A. Alfonso-Jaume, M.R. Bergman, and R. Mahimkar Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB Am J Physiol Heart Circ Physiol 291 2006 H1838
21. R. Mohan, W.B. Rinehart, and P. Bargagna-Mohan Gelatinase B/lacZ transgenic mice, a model for mapping gelatinase B expression during developmental and injury-related tissue remodeling J Biol Chem 273 1998 25903
22. A.M. Flenniken, and B.R. Williams Developmental expression of the endogenous TIMP gene and a TIMP-lacZ fusion gene in transgenic mice Genes Dev 4 1990 1094
23. K. Nichols, D. Lefkowitz, and T. Faber Echocardiographic validation of gated SPECT ventricular function measurements J Nucl Med 41 2000 1308
24. F.A. Tortoledo, M.A. Quinones, and G.C. Fernandez Quantification of left ventricular volumes by two-dimensional echocardiography: A simplified and accurate approach Circulation 67 1983 579
25. S. Heymans, A. Luttun, and D. Nuyens Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure Nat Med 5 1999 1135
26. B.I. Jugdutt, M.J. Joljart, and M.I. Khan Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models Circulation 94 1996 94
27. M.G. Sutton, and N. Sharpe Left ventricular remodeling after myocardial infarction: Pathophysiology and therapy Circulation 101 2000 2981
28. J. D'Armiento Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction Trends Cardiovasc Med 12 2002 97
29. S.C. Tyagi, S.G. Kumar, and S.J. Haas Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy J Mol Cell Cardiol 28 1996 1415
30. A.M. Deschamps, W.M. Yarbrough, and C.E. Squires Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: Relation to interstitial membrane type-1 matrix metalloproteinase activity Circulation 111 2005 1166
31. A.M. Deschamps, and F.G. Spinale Pathways of matrix metalloproteinase induction in heart failure: Bioactive molecules and transcriptional regulation Cardiovasc Res 69 2006 666
32. R. Visse, and H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry Circ Res 92 2003 827
33. E. Lutgens, M.J. Daemen, and E.D. de Muinck Chronic myocardial infarction in the mouse: Cardiac structural and functional changes Cardiovasc Res 41 1999 586
34. P. Camelliti, G.P. Devlin, and K.G. Matthews Spatially and temporally distinct expression of fibroblast connexins after sheep ventricular infarction Cardiovasc Res 62 2004 415
35. A.S. Blom, J.J. Pilla, and J. Arkles Ventricular restraint prevents infarct expansion and improves borderzone function after myocardial infarction: A study using magnetic resonance imaging, three-dimensional surface modeling, and myocardial tagging Ann Thorac Surg 84 2007 2004
36. F. Yang, Y.H. Liu, and X.P. Yang Myocardial infarction and cardiac remodelling in mice Exp Physiol 87 2002 547